Skip to main content
Article
Inpatient Palliative Care Use among Critically III Brain Metastasis Patients in the United States
Department of Biostatistics Faculty Publications
  • Muni Rubens, Baptist Health South Florida
  • Venkataraghavan Ramamoorthy, University of Central Missouri
  • Anshul Saxena, Florida International University
  • Peter McGranaghan, Baptist Health South Florida
  • Chintan Bhatt, Florida International University
  • Sankalp Das, Florida International University
  • Nancy Shehadeh, Herbert Wertheim College of Medicine
  • Emir Veledar, Florida International University
  • Ana Viamonte-Ros, Florida International University
  • Yazmin Odia, Baptist Health South Florida
  • Minesh P. Mehta, Baptist Health South Florida
  • Rupesh Kotecha, Baptist Health South Florida
Date of this Version
11-1-2020
Document Type
Article
Abstract

Objective:The objective of this study was to understand the trends and characteristics of palliative care delivery among critically ill brain metastasis patients using a nationally representative database.Materials and Methods:This study was a retrospective analysis of Nationwide Inpatient Sample data collected during 2005 to 2014. This study included critically ill patients, 18 years and above, diagnosed with brain metastasis, identified using International Classification of Diseases-Ninth Revision-Clinical Modification diagnosis and procedure codes. Multivariable logistic regression models were used for predicting factors associated with inpatient palliative care use.Results:Among 18,309 critically ill patients with brain metastasis, 3298 (18.0%) received inpatient palliative care. The rate of inpatient palliative care use among these patients increased from 3.2% to 28.5%, during 2005 to 2014 (P<0.001). Regression analysis showed that hospital teaching status (odds ratio [ORs], 1.45; 95% confidence interval [CI], 1.14-1.84), primaries located in head and neck (OR, 1.42; 95% CI, 1.21-2.05) or lung (OR, 1.32; 95% CI, 1.22-1.44), and primary diagnosis of pneumonia (OR, 1.42; 95% CI, 1.22-1.97) or septicemia (OR, 1.59; 95% CI, 1.30-1.97), were associated with higher palliative care use. Hispanic ethnicity (OR, 0.86; 95% CI, 0.67-0.96), and hospital location in Northeast (OR, 0.73; 95% CI, 0.54-0.96), Midwest (OR, 0.63; 95% CI, 0.45-0.87), or South (OR, 0.64; 95% CI, 0.48-0.86) were associated with lower palliative care use.Conclusions:Inpatient palliative care use increased significantly among critically ill patients with brain metastases, though overall rate was low. There were geographical and racial disparities among these patients. Health care providers and policy makers should focus on decreasing these disparities. In addition, hospitals should focus on adopting more palliative care services.

Citation Information
Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Peter McGranaghan, et al.. "Inpatient Palliative Care Use among Critically III Brain Metastasis Patients in the United States" (2020)
Available at: http://works.bepress.com/emir-veledar/401/